Medisca, dsm-firmenich To Expand Vitamin APIs Access For US Market
KUALA LUMPUR, May 13 (Bernama) -- Medisca, a leader in personalised pharmaceutical medicine, has entered into a strategic partnership with dsm–firmenich to expand access to pharmaceutical-grade vitamin active pharmaceutical ingredients (APIs) for the United States (US) compounding market.
Under the agreement, Medisca will distribute vitamin APIs manufactured in European current Good Manufacturing Practice (cGMP)-compliant facilities and supported by established quality systems and documentation standards.
This partnership reflects a long-term commitment to expanding access to high-quality ingredient solutions while preserving the workflows, relationships, and operational models customers rely on today.
Medisca Vice President, Strategic Partnerships, Peng Li said ingredient sourcing remains central to trust and long-term success in pharmaceutical compounding.
“By bringing dsm-firmenich pharmaceutical-grade API portfolio into the Medisca ecosystem, we are expanding what our customers can rely on today and supporting how the industry continues to evolve,” Li said in a statement.
Meanwhile, dsm-firmenich Senior Sales Director, Jennifer McManus said the collaboration would help improve supply reliability and operational confidence for compounding professionals in the US market.
“By combining our global manufacturing expertise and commitment to cGMP standards with Medisca’s deep understanding of compounding professionals, we are strengthening supply reliability and enabling pharmacies and 503B outsourcing facilities to operate with greater confidence, consistency, and quality in patient care,” she added.
The partnership introduces pharmaceutical-grade vitamin APIs through an established commercial and technical model designed to support regulated use and long-term continuity across compounding practice.
The dsm–firmenich vitamin API portfolio is now available through Medisca in the US, with additional products expected to be introduced over time.
-- BERNAMA